Literature DB >> 2049071

Cloning, expression, isolation and characterization of the pre-S domains of hepatitis B surface antigen, devoid of the S protein.

S Delos1, M T Villar, P Hu, D L Peterson.   

Abstract

The 'pre-S' parts of the envelope protein of hepatitis B virus (HBV) have been proposed to be involved in the infection of hepatocytes by HBV. In order to facilitate the study of these processes, we have developed an expression system to allow the production and purification of large quantities of the pre-S protein. To obtain a protein containing all of the pre-S sequence and only this sequence, mutations were introduced into the HBV(ayw) genome to create an NdeI restriction site at the initial ATG of the large surface protein gene. Also, stop codons and a BglII restriction site were introduced after the last codon of pre-S2. This fragment was then cloned into the high-expression vector pET-3A. A protein of the expected Mr was expressed at a level of up to 10% of the total soluble protein in HMS174 (DE3) cells, as judged by SDS/PAGE. A rapid purification method has been developed for this protein. The protein retains the polyalbumin-binding activity ascribed to the pre-S2 sequence, and is recognized by both polyclonal and monoclonal antibodies directed against pre-S determinants. Gel filtration chromatography demonstrates that the protein is monomeric and globular, and c.d. spectroscopy indicates that beta-sheet is the major periodic structure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049071      PMCID: PMC1151107          DOI: 10.1042/bj2760411

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Spectroscopic determination of tryptophan and tyrosine in proteins.

Authors:  H Edelhoch
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

3.  Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.

Authors:  D R Milich; A McLachlan; F V Chisari; S B Kent; G B Thorton
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

4.  Calculation of protein conformation from circular dichroism.

Authors:  J T Yang; C S Wu; H M Martinez
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

5.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

6.  Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure.

Authors:  A Ben-Bassat; K Bauer; S Y Chang; K Myambo; A Boosman; S Chang
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

7.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

8.  Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins.

Authors:  M A Petit; P Maillard; F Capel; J Pillot
Journal:  Mol Immunol       Date:  1986-05       Impact factor: 4.407

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 10.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

View more
  5 in total

1.  The serology of chronic hepatitis B infection revisited.

Authors:  T Maruyama; A McLachlan; S Iino; K Koike; K Kurokawa; D R Milich
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

2.  Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.

Authors:  C O Tacket; S M Kelly; F Schödel; G Losonsky; J P Nataro; R Edelman; M M Levine; R Curtiss
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Expression and purification of the complete PreS region of hepatitis B Virus.

Authors:  Qiang Deng; Yu-Ying Kong; You-Hua Xie; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

4.  Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain.

Authors:  D Nardelli-Haefliger; J P Kraehenbuhl; R Curtiss; F Schodel; A Potts; S Kelly; P De Grandi
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.

Authors:  F Schödel; S M Kelly; D L Peterson; D R Milich; R Curtiss
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.